Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Darren Cross

4PUBLICATIONS
55CO-AUTHORS
Molecular targetsGene and molecular therapyProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Dec 12, 2022
Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer.

Sally J Adua, Anna Arnal-Estapé, Minghui Zhao

|Oct 20, 2022
Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor-Mutated, MET-Amplified Non-Small Cell Lung Cancer: TATTON.

Ryan J Hartmaier, Aleksandra A Markovets, Myung Ju Ahn

|Sep 13, 2021
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of <i>EGFR</i>-mutant lung cancer.

Pınar Özden Eser, Raymond M Paranal, Jieun Son

|May 18, 2021
Kinase drug discovery 20 years after imatinib: progress and future directions.

Philip Cohen, Darren Cross, Pasi A Jänne

Pageof 1

Frequent Collaborators

3 joint publications

Pasi A Jänne

2 joint publications

Paul Smith

1 joint publications

Ryan J Hartmaier

1 joint publications

Aleksandra A Markovets

1 joint publications

Myung Ju Ahn

1 joint publications

Lecia V Sequist

1 joint publications

Ji-Youn Han

1 joint publications

Byoung Chul Cho

1 joint publications

Don X Nguyen

1 joint publications

Sang-We Kim

Frequent Collaborators

3 joint publications

Pasi A Jänne

2 joint publications

Paul Smith

1 joint publications

Ryan J Hartmaier

1 joint publications

Aleksandra A Markovets

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

8.9K
See more related videos

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

8.9K
See more related videos